Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders | Synapse
May 6, 2026Open Access
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders
Key Points
The aim is to explore the effectiveness of heterobifunctional protein degraders targeting ALK2.
Development of compounds with improved degradation potency for ALK2.
Evaluation of the utility of these compounds in studying ALK2's role in disease.
Identified compounds enhance the degradation of ALK2.
Demonstrated potential applications in drug discovery for human diseases.
Abstract
), a compound with improved ALK2 degradation potency. The compounds described have utility for studying the role of ALK2 in human disease and possess translational potential in drug discovery.